{"id":4415,"date":"2019-03-26T05:01:40","date_gmt":"2019-03-26T05:01:40","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?post_type=study_trials&#038;p=4415"},"modified":"2020-11-03T20:47:02","modified_gmt":"2020-11-03T20:47:02","slug":"uno-studio-sulla-sicurezza-la-tollerabilita-e-la-farmacocinetica-del-dcc-2618-in-pazienti-affetti-da-neoplasie-in-stadio-avanzato","status":"publish","type":"study_trials","link":"https:\/\/www.erdheim-chester.org\/it\/study_trials\/a-safety-tolerability-and-pk-study-of-dcc-2618-in-patients-with-advanced-malignancies\/","title":{"rendered":"Uno studio sulla sicurezza, la tollerabilit\u00e0 e la farmacocinetica del DCC-2618 in pazienti affetti da neoplasie in stadio avanzato"},"content":{"rendered":"<p><strong>Obiettivo dello studio:<\/strong>&nbsp; Si tratta di uno studio di fase 1 volto a valutare la sicurezza e l'efficacia del farmaco sperimentale DCC-2618, somministrato per via orale (PO), in pazienti adulti affetti da neoplasie in stadio avanzato.<br \/>\n<strong>Sponsor:<\/strong>&nbsp; Deciphera Pharmaceuticals LLC<br \/>\n<strong>Informazioni di contatto per la fase di prova:<\/strong>&nbsp; Divya Sakamuri; 1-713-745-3296; dsakamuri@mdanderson.org oppure Filip Janku; 713-563-1930; FJanku@mdanderson.org<br \/>\n<strong>Coinvolgimento richiesto del paziente:<\/strong>&nbsp; Pazienti affetti da ECD di et\u00e0 pari o superiore a 18 anni.<br \/>\n<strong>Centri noti che accettano pazienti affetti da ECD nell\u2019ambito dello studio:<\/strong>&nbsp; MD Anderson, Houston, Texas<br \/>\n<strong>Identificativo su ClinicalTrials.gov:<\/strong>&nbsp; NCT02571036<\/p>","protected":false},"excerpt":{"rendered":"<p>Study Objective:&nbsp; This is a Phase 1 trial to investigate the safety and efficacy of the investigational drug, DCC-2618, administered orally (PO), in adult patients with advanced malignancies. Sponsor:&nbsp; Deciphera [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_study_trials_cat":0,"_links_to":"","_links_to_target":""},"study_trials_cat":[32],"class_list":["post-4415","study_trials","type-study_trials","status-publish","hentry","study_trials_cat-drug-trial"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/study_trials\/4415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/study_trials"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/types\/study_trials"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/media?parent=4415"}],"wp:term":[{"taxonomy":"study_trials_cat","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/it\/wp-json\/wp\/v2\/study_trials_cat?post=4415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}